Phase 1/2 clinical study of irinotecan and oral S-1 (IRIS) in patients with advanced gastric cancer.
Komatsu Y, Yuki S, Fuse N, Kato T, Miyagishima T, Kudo M, Kunieda Y, Tateyama M, Wakahama O, Meguro T, Sakata Y, Asaka M.
Komatsu Y, et al. Among authors: yuki s.
Adv Ther. 2010 Jul;27(7):483-92. doi: 10.1007/s12325-010-0037-2. Epub 2010 Jun 16.
Adv Ther. 2010.
PMID: 20559897
Clinical Trial.